| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |